FOLLICULOTROPIC MYCOSIS FUNGOIDES
Clinical trials for FOLLICULOTROPIC MYCOSIS FUNGOIDES explained in plain language.
Never miss a new study
Get alerted when new FOLLICULOTROPIC MYCOSIS FUNGOIDES trials appear
Sign up with your email to follow new studies for FOLLICULOTROPIC MYCOSIS FUNGOIDES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy and chemo join forces against tough lymphoma
Disease control Recruiting nowThis study tests two drugs—durvalumab (an immunotherapy) and lenalidomide (a chemotherapy drug)—alone or together in people with T-cell lymphoma that has returned or not responded to prior treatment. The goal is to find the best dose and see how well the combination works. About …
Matched conditions: FOLLICULOTROPIC MYCOSIS FUNGOIDES
Phase: PHASE1, PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
New combo therapy hopes to tackle rare skin cancer
Disease control Recruiting nowThis phase II trial tests whether combining a targeted antibody drug (mogamulizumab) with a procedure that treats white blood cells with light (extracorporeal photopheresis) can better control erythrodermic cutaneous T-cell lymphoma, a rare skin cancer. About 34 adults with advan…
Matched conditions: FOLLICULOTROPIC MYCOSIS FUNGOIDES
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC